Differential expression of proteoglycans biglycan and decorin during neointima formation after stent implantation in normal and atherosclerotic rabbit aortas

Atherosclerosis

Volumn 152, Issue 2, 2000, Pages 287-298

  Yamakawa, Tomoyuki ^a   Bai, Hong Zhi ^a   Masuda, Junichi ^b   Sawa, Yoshiki ^a   Shirakura, Ryota ^c   Ogata, Jun ^d   Matsuda, Hikaru ^a  

^a O   (Japan)

^b SHIMANE UNIVERSITY   (Japan)

^c OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^d NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

Extracellular matrix; Imunohistochemistry; In situ hybridization; Proteoglycan; Restenosis; Stent

Indexed keywords

BIGLYCAN; CYTOKINE; DECORIN; INTERLEUKIN 1BETA; MESSENGER RNA; PROTEOGLYCAN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ATHEROSCLEROSIS; ARTICLE; CONTROLLED STUDY; EXTRACELLULAR MATRIX; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INTIMA; NONHUMAN; PRIORITY JOURNAL; RABBIT; STENT;

EID: 0033821877     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(99)00475-X     Document Type: Article

References (35)

1. Schatz R.A., Baim D.S., Leon M., Ellis S.G., Goldberg S., Hirshfeld J.W., Cleman M.W., Cabin H.S., Walker C., Stagg J., et al. Clinical experience with the Palmaz-Schatz coronary stent: initial results of multicenter study. Circulation. 83:1991;148-161.
2. Serruys P.W., Jaegere P., Kiemeneij F., Maacaya C., Rutsch W., Heyndrckx G., Emanuelsson H., Marco J., Legrand V., Materne, et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. N. Engl. J. Med. 441:1994;489-495.
3. Fischman D.L., Leon M.B., Baim D.S., Schatz R.A., Savage M.P., Penn L., Detre K., Veltri L., Ricci D., Nobuyoshi M., Cleman M., et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N. Engl. J. Med. 331:1994;496-501.
4. Bai H., Masuda J., Sawa Y., Nakano S., Shirakura R., Shimazaki Y., Ogata J., Matsuda H. Neointima formation after vascular stent implantation: spatial and chronological distribution of smooth muscle cell proliferation and phenotypic modulation. Arterioscler. Thromb. 14:1994;1846-1853.
5. Stary H.C., Blankenhorn D.H., Chandler A.B., Glagpv S., Insull W., Richardson M., Rosenfeld M.E., Schaffer S.A., Schwartz C.J., Wagner W.D., Wissler R.W. A definition of the intima of human arteries and of its atherosclerosis-prone regions. A report from the committee on vascular lesions of the council on arteriosclerosis, American Heart Association. Arterioscler. Thromb. 12:1992;120-134.
6. Madri J.A., Kocher O., Merwin J.R., Bell L., Tucker A., Basson C.T. Interactions of vascular cells with transforming growth factors-β Ann. New York Acad. Sci. 593:1990;243-258.
7. Thyberg J., Hedin U., Sjöund M., Palmberg L., Bottger B.A. Regulation of differentiated properties and proliferation of arterial smooth muscle cells. Arteriosclerosis. 10:1990;966-990.
8. Ruoslahti E., Yamaguchi Y. Proteoglycans as modulators of growth factor activities. Cell. 64:1991;867-869.
9. Krull N.B., Zimmermann T., Gressner A.M. Spatial and temporal patterns of gene expression for the proteoglycans biglycan and decorin and transforming growth factor-β1 revealed by in situ hybridization during experimentally induced liver fibrosis in the rat. Hepatology. 18:1993;581-589.
10. Westergren-Thorsson G., Hernnäs J., Särnstrand B., Oldberg Å., Heinegård D., Malmström A. Altered expression of small proteoglycans, collagen, and transforming growth factor-β1 in developing bleomycin-induced pulmonary fibrosis in rats. J. Clin. Invest. 92:1993;632-637.
11. Riessen R., Isner J.M., Blessing E., Loushin C., Nikol S., Wight T.N. Regional differences in the distribution of the proteoglycans biglycan and decorin in the extracellular matrix of atherosclerotic and restenotic human coronary arteries. Am. J. Pathol. 144:1994;962-974.
12. Sporn M.B., Roberts A.B. Transforming growth factor β: multiple actions and potential clinical applications. J. Am. Med. Assoc. 262:1989;938-948.
13. Roberts A.B., Heine U.I., Flanders K.C., Sporn M.B. Transforming growth factor-β: major role in regulation of extracellular matrix. Ann. New York Acad. Sci. 580:1990;225-232.
14. Yamaguchi Y., Mann D.M., Ruoslahti E. Negative regulation of transforming growth factor-β by the proteoglycan decorin. Nature. 346:1990;281-284.
15. Border W.A., Noble N.A., Yamamoto T., Harper J.R., Yamaguchi Y., Pierschbacher M.D., Ruoslahti E. Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney disease. Nature. 360:1992;361-364.
16. Edwards I.J., Xu H., Wright M.J., Wagner W.D. Intrerleukin-1 upregulates decorin production by arterial smooth muscle cells. Arterioscler. Thromb. 14:1994;1032-1039.
17. Hirota S., Ito A., Mori E., Wanaka A., Tohyama M., Kitamura Y., Nomura S. Localization of mRNA for c-kit receptor and its ligand in the brain of adult rats: an analysis using in situ hybridization. Mol. Brain Res. 15:1992;47-54.
18. Masuda J., Ross R. Atherogenesis during low level hypercholesterolemia in the nonhuman primate. I. Fatty streak formation. Arteriosclerosis. 10:1990;164-177.
19. Kuro-o M., Nagai R., Nakahara K., Katoh H., Tsai R.C., Tsuchimori H., Yazaki Y., Ohkubo A., Takaku F. cDNA cloning of a myosin heavy chain isoform in embryonic smooth muscle and its expression during vascular development and in arteriosclerosis. J. Biol. Chem. 266:1991;3768-3773.
20. Aikawa M., Sivam P.N., Kuro-o M., Kimura K., Nakahara K., Takeuchi S., Ueda M., Yamaguchi H., Yazaki Y., Periasamy M., Nagai R. Human smooth muscle myosin heavy chain isoforms as molecular markers for vascular development and atherosclerosis. Circ. Res. 73:1993;1000-1012.
21. Nikol S., Isner J.M., Pickering J.G., Kearney M., Lecierc G., Weir L. Expression of transforming growth factor-β1 is increased in human vascular restenosis lesions. J. Clin. Invest. 90:1992;1582-1592.
22. Majesky M.W., Lindner V., Twardzik D.R., Schwartz S.M., Reidy M.A. Production of transforming growth factor β1 during repair of arterial injury. J. Clin. Invest. 88:1991;904-910.
23. Nabel E.G., Shum L., Pompili V.J., Yang Z., San H., Shu H.B., Liptay S., Gold L., Gordon D., Derynck R., Nabel G.J. Direct transfer of transforming growth factor β1 gene into arteries stimulates fibrocellular hyperplasia. Proc. Natl. Acad. Sci. USA. 90:1993;10759-10763.
24. Wight T.N., Curwen K.D., Litrenta M.M., Alonso D.R., Minick C.R. Effect of endothelium on glycosaminoglycan accumulation in injured rabbit aorta. Am. J. Pathol. 113:1983;156-164.
25. Merrilees M.J., Scott L.J. Effects of endothelial removal and regeneration on smooth muscle glycosaminoglycan synthesis and growth in rat carotid artery in organ culture. Lab. Invest. 52:1985;409-419.
26. Nikkari S.T., Järveläinen H.T., Wight T.N., Ferguson M., Clowes A.W. Smooth muscle cell expression of extracellular matrix genes after arterial injury. Am. J. Pathol. 144:1994;1348-1356.
27. Lin H., Wilson J.E., Roberts C.R., Horley K.J., Winters G.L., Costanzo M.R., McManus B.M. Biglycan, decorin and versican protein expression patterns in coronary arteriopathy of human cardiac allografts: distinctness as compared with native atherosclerosis. J. Heart Lung Trans. 15:1996;1233-1247.
28. Edwards I.J., Wagner W.D., Owens R.T. Macrophage secretory products selectively stimulate dermatan sulfate proteoglycan production in cultured arterial smooth muscle cells. Am. J. Pathol. 136:1990;609-621.
29. Heino J., Kähäri V.M., Mauviel A., Krusius T. Human recombinant interleukin-1 regulates cellular mRNA levels of dermatan sulfate proteoglycan core protein. Biochem. J. 252:1988;309-312.
30. Pulkkinen L., Kainulainen K., Krusius T., Mkinen P., Schollin J., Gustavsson K.H., Peltonen. Deficient expression of the gene coding for decorin in a lethal form of Marfan syndrome. J. Biol. Chem. 265:1990;17780-17785.
31. Kähäri V.M., Larjava H., Uitto J. Differential regulation of extracellular matrix proteoglycan (PG) gene expression: transforming growth factor β1 up-regulates biglycan (PGI) and versican (large fibroblast PG) but down-regulates decorin (PGII) mRNA levels in human fibroblasts in culture. J. Biol. Chem. 266:1991;10608-10615.
32. Westergren-Thorsson G., Antonsson P., Malmström A., Heinegård D., Oldberg Å. The synthesis of a family of structurally related proteoglycans in fibroblasts is differently regulated by TGF-β Matrix. 11:1991;177-183.
33. Westergren-Thorsson G., Schmidtchen A., Särnstrand B., Fransson L., Malmström A. Transforming growth factor-β induces selective increase of proteoglycan production and changes in copolymeric structure of dermatan sulphate in human skin fibroblasts. Eur. J. Biochem. 205:1992;277-286.
34. Mauviel A., Santra M., Chen Y.Q., Uitto J., Iozzo R.V. Transcriptional regulation of decorin gene expression. Induction by quiescence and repression by tumor necrosis factor-alpha. J. Biol. Chem. 20:1995;11692-11700.
35. Schönherr E., Järveläinen H.T., Kinsella M.G., Sandell L.J., Wight T.N. Platelet-derived growth factor and transforming growth factor-β1 differentially affect the synthesis of biglycan and decorin by monkey arterial smooth muscle cells. Arterioscler. Thromb. 13:1993;1026-1036.